Randomized Phase III Study of FOLFOX Alone and with Pegilodecakin as Second-line Therapy in Patients with Metastatic Pancreatic Cancer (SEQUOIA)

Hecht, JR; Lonardi, S; Bendell, JC; Sim, HW; Macarulla, T; Lopez, CD; Van Cutsem, E; Martin, AJM; Park, JO; Greil, R; Lin, Y; Rao, S; Ryoo, BY

View this publication in the PUBMED database